Tiotropium for stable chronic obstructive pulmonary disease

Author:

Barr R Graham1,Bourbeau Jean2,Camargo Jr Carlos A3

Affiliation:

1. Columbia-Presbyterian Medical Center; Division of General Medicine, PH-9 East Room 105; 622 West 168th Street New York NY USA 10032

2. McGill University Health Centre; Respiratory Division, Department of Medicine; Montreal Chest Institute 3650 St-Urbain Montreal QC Canada H2X 2P4

3. Massachusetts General Hospital; Department of Emergency Medicine; 326 Cambridge St, Suite 410 Boston Massachusetts USA 02114

Publisher

Wiley

Subject

Pharmacology (medical)

Reference91 articles.

1. Efficacy of tiotropium (Spiriva) in COPD of different severities (abstract);Beeh;Pneumologie,2004

2. Efficacy of tiotropium in patients with mild-to-moderate COPD (abstract);Beeh;Amercian Journal of Respiratory and Critical Care Medicine,2004

3. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD;Brusasco;Thorax,2003

4. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease;Calverley;Thorax,2003

5. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group;Casaburi;Chest,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3